Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11350925 | 0.79 | TSHR (0.43) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL5076450 | 0.79 | — | — | |
| SCHEMBL6729264 | 0.77 | TSHR (0.42) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL17319467 | 0.77 | TSHR (0.42) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL2233250 | 0.77 | TSHR (0.42) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL23805180 | 0.75 | TSHR (0.40) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL225628 | 0.75 | CA2 (0.40) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL21124793 | 0.75 | CA2 (0.40) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL5076462 | 0.75 | TSHR (0.40) | TSHRTP53CA12CA1CA2 | |
| SCHEMBL5075620 | 0.75 | TSHR (0.40) | TSHRTP53CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103833723-B | The manufacture method of cyclic sulfonic acid ester and intermediate thereof | 和光纯药工业株式会社 | 2016-08-17 | — | — | CN | disclosed |
| EP-2757102-B1 | Intermediate for producing a cyclic sulfonic acid ester | WAKO PURE CHEM IND LTD (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-8969591-B2 | Method for producing cyclic sulfonic acid ester and intermediate thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| EP-2463281-B1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEM IND LTD (JP) | 2014-10-22 | — | — | EP | disclosed |
| EP-2757102-A1 | 1,3-propanesultone derivative useful in the preparation of a 1,3-propenesultone derivative | Wako Pure Chemical Industries, Ltd. (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-20140142324-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-8673963-B2 | Method for producing cyclic sulfonic acid ester and intermediate thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-18 | — | — | US | disclosed |
| EP-2463281-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | Wako Pure Chemical Industries, Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120130089-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| CN-102471305-A | Process for producing cyclic sulfonic acid ester and intermediate thereof | WAKO PURE CHEM IND LTD | 2012-05-23 | — | — | CN | disclosed |
| EP-1413572-B1 | PROCESS FOR PRODUCING ACID ANHYDRIDE | TOKUYAMA CORP (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-7220881-B2 | Process for production of acid anhydride | TOKUYAMA CORPORATION (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20040242929-A1 | Process for production of acid anhydride | TOKUYAMA CORPORATION (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1413572-A1 | PROCESS FOR PRODUCING ACID ANHYDRIDE | Tokuyama Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142324-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | STS, TST, SULT1A1 | TSHR 1305/4885TP53 4627/4885CA12 282/4885 |
| US-20120130089-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | STS, TST, SULT1A1 | TSHR 1305/4885TP53 4627/4885CA12 282/4885 |
| US-20040242929-A1 | Process for production of acid anhydride | CA4, CA9, CA6 | TSHR 565/4885TP53 4087/4885CA12 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.